ZP3 and cancer: To obtain an initial insight into the oncogenic characteristics of ZP3-Cancer, curated pathological (tumor stage and grade) and clinical (OS, PFI, DFI, DSS) data for the tumors and patients included in the TCGA were used to explore a relationship between these parameters and the ZP3-Cancer expression level.